247 related articles for article (PubMed ID: 34553788)
1. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
[TBL] [Abstract][Full Text] [Related]
2. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
3. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.
Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X
Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806
[No Abstract] [Full Text] [Related]
4. miR-1202 regulates BPH-1 cell proliferation, apoptosis, and epithelial-to-mesenchymal transition through targeting HMGCL.
Wang Z; Yin X; Yang P; Gong B; Liu H
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):675-687. PubMed ID: 38551020
[TBL] [Abstract][Full Text] [Related]
5. BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons
Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
J Neurosci; 2018 Feb; 38(7):1662-1676. PubMed ID: 29321139
[TBL] [Abstract][Full Text] [Related]
6. NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia.
Liu J; Liu D; Zhang X; Li Y; Fu X; He W; Li M; Chen P; Zeng G; DiSanto ME; Wang X; Zhang X
Clin Sci (Lond); 2021 Jul; 135(13):1591-1608. PubMed ID: 34195782
[TBL] [Abstract][Full Text] [Related]
7. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
Kim HJ; Jin BR; An HJ
Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (
Liu D; Li M; Fu X; Yang S; Wang Z; Liu J; Li Y; Zhou Y; Ren P; Guo Y; Wang X; DiSanto ME; Chen P; Zhang X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613500
[TBL] [Abstract][Full Text] [Related]
9. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
10. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional activity of Nik related kinase (NRK) in benign hyperplastic prostate.
He W; Tian Z; Dong B; Cao Y; Hu W; Wu P; Yu L; Zhang X; Guo S
J Transl Med; 2024 Mar; 22(1):255. PubMed ID: 38459501
[TBL] [Abstract][Full Text] [Related]
12. Glucose-regulated protein 78 modulates cell growth, epithelial-mesenchymal transition, and oxidative stress in the hyperplastic prostate.
Fu X; Liu J; Liu D; Zhou Y; Guo Y; Wang Z; Yang S; He W; Chen P; Wang X; DiSanto ME; Zhang X
Cell Death Dis; 2022 Jan; 13(1):78. PubMed ID: 35075122
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
15. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate.
Li Y; Zhou Y; Liu D; Wang Z; Qiu J; Zhang J; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
J Transl Med; 2023 Aug; 21(1):575. PubMed ID: 37633909
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.
Shan S; Su M; Li Y; Wang Z; Liu D; Zhou Y; Fu X; Yang S; Zhang J; Qiu J; Liu H; Zeng G; Chen P; Wang X; DiSanto ME; Guo Y; Zhang X
Mol Med; 2023 Oct; 29(1):139. PubMed ID: 37864185
[TBL] [Abstract][Full Text] [Related]
17. STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.
Liu J; Zhou W; Yang L; Li Y; Qiu J; Fu X; Ren P; Guo F; Zhou Y; Liu J; Chen P; DiSanto ME; Zhang X
Cell Signal; 2024 Jan; 113():110933. PubMed ID: 37866665
[TBL] [Abstract][Full Text] [Related]
18. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
19. GREM1 knockdown regulates the proliferation, apoptosis and EMT of benign prostatic hyperplasia by suppressing the STAT3/c-Myc signaling.
Sun X; Jiang M; Wang Z; Xu C; Ma Z
Tissue Cell; 2024 Feb; 86():102231. PubMed ID: 37931534
[TBL] [Abstract][Full Text] [Related]
20. Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways.
Liu CM; Shao Z; Chen X; Chen H; Su M; Zhang Z; Wu Z; Zhang P; An L; Jiang Y; Ouyang AJ
Saudi Pharm J; 2023 Jul; 31(7):1219-1228. PubMed ID: 37293563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
